CNN @CNN
The death of a participant in a clinical trial of an antibody treatment for Alzheimer’s disease, which is now under consideration by the US Food and Drug Administration, may be linked to the experimental drug, a new report shows. https://t.co/1cUQJ7W25G — PolitiTweet.org